Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
Xiang Zhang, Olabisi Oluwabukola Coker, Eagle SH Chu, et al.
Gut (2020) Vol. 70, Iss. 4, pp. 761-774
Open Access | Times Cited: 623

Showing 1-25 of 623 citing articles:

Immune cell-mediated features of non-alcoholic steatohepatitis
Thierry Huby, Emmanuel L. Gautier
Nature reviews. Immunology (2021) Vol. 22, Iss. 7, pp. 429-443
Open Access | Times Cited: 383
Gut-liver axis: Pathophysiological concepts and clinical implications
Herbert Tilg, Timon E. Adolph, Michael Trauner
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1700-1718
Open Access | Times Cited: 364
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 704-712
Open Access | Times Cited: 321
Role of the gut microbiota in type 2 diabetes and related diseases
Ge Yang, Jinlong Wei, Pinyi Liu, et al.
Metabolism (2021) Vol. 117, pp. 154712-154712
Closed Access | Times Cited: 289
Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis
Yong Rao, Zhiqi Kuang, Chan Li, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 215
Short-chain fatty acids in diseases
Dan Zhang, Yong‐Ping Jian, Yuning Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 196
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
Natalia G. Vallianou, Gerasimos Socrates Christodoulatos, Ιrene Karampela, et al.
Biomolecules (2021) Vol. 12, Iss. 1, pp. 56-56
Open Access | Times Cited: 182
Gut–liver axis: barriers and functional circuits
Oliver Pabst, Mathias W. Hornef, Frank G. Schaap, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 7, pp. 447-461
Closed Access | Times Cited: 166
New Insights Into Gut-Bacteria-Derived Indole and Its Derivatives in Intestinal and Liver Diseases
Xiaojing Li, Binbin Zhang, Yiyang Hu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 141
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
Chen Chen, Zehua Wang, Yi Ding, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 134
Excess body weight: Novel insights into its roles in obesity comorbidities
Xiang Zhang, Suki Ha, Harry Cheuk-Hay Lau, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 16-27
Open Access | Times Cited: 111
Asian perspective on NAFLD-associated HCC
Terry Cheuk‐Fung Yip, Hye Won Lee, Wah‐Kheong Chan, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 3, pp. 726-734
Closed Access | Times Cited: 109
A researcher’s guide to preclinical mouse NASH models
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, et al.
Nature Metabolism (2022) Vol. 4, Iss. 12, pp. 1632-1649
Closed Access | Times Cited: 107
Endoplasmic reticulum stress and lipids in health and diseases
Cenk Celik, Stella Yue Ting Lee, Wei Sheng Yap, et al.
Progress in Lipid Research (2022) Vol. 89, pp. 101198-101198
Closed Access | Times Cited: 106
Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
Agnieszka Karkucińska‐Więckowska, Inês C. M. Simões, Piotr Kalinowski, et al.
European Journal of Clinical Investigation (2021) Vol. 52, Iss. 3
Open Access | Times Cited: 105
A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Qiqing Yang, Bin Wang, Qinghui Zheng, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 100
Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma
Qian Song, Xiang Zhang, Weixin Liu, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 6, pp. 1352-1365
Open Access | Times Cited: 96
Gut microbiota bridges dietary nutrients and host immunity
Lijuan Fan, Yaoyao Xia, Youxia Wang, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 11, pp. 2466-2514
Open Access | Times Cited: 91
Desulfovibrio in the Gut: The Enemy within?
Sudha Singh, Amanda Carroll‐Portillo, Henry C. Lin
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1772-1772
Open Access | Times Cited: 91
The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
Qian Song, Xiang Zhang
Biomedicines (2022) Vol. 10, Iss. 3, pp. 524-524
Open Access | Times Cited: 88
Gut Microbiota Participates in Polystyrene Microplastics-Induced Hepatic Injuries by Modulating the Gut–Liver Axis
Kai-Kai Zhang, Jian-Zheng Yang, Lijian Chen, et al.
ACS Nano (2023) Vol. 17, Iss. 15, pp. 15125-15145
Closed Access | Times Cited: 83
Microplastics: What happens in the human digestive tract? First evidences in adults using in vitro gut models
E Fournier, Mathilde Lévêque, Philippe Ruiz, et al.
Journal of Hazardous Materials (2022) Vol. 442, pp. 130010-130010
Open Access | Times Cited: 77
The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
Ali Nabavi-Rad, Amir Sadeghi, Hamid Asadzadeh Aghdaei, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 76
Mitochondrial cholesterol: Metabolism and impact on redox biology and disease
Leire Goicoechea, Laura Conde de la Rosa, Sandra Torres, et al.
Redox Biology (2023) Vol. 61, pp. 102643-102643
Open Access | Times Cited: 72
METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy
Yasi Pan, Huarong Chen, Xiang Zhang, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 8, pp. 101144-101144
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top